Open to all Yale affiliates, this program is designed to give an introduction to the field of biotechnology investment and acquire the knowledge of how to break into the industry.

Yale Biotech Club 2026 Bioinvestment & VC Series

Session goal: Examine exit pathways (licensing deals and M&A) and understand how these strategies shape VC returns and company strategy.

Session 5: Strategic Growth & Exit Pathways       Featuring Ranjit Bindra, MD PhD; Professor at Yale, Serial Biotech Entrepreneur.

Jeffrey C Miller

Dustin Walters

Qiao Li

Lori

Timothy Paris

Khang Nguyen

Filip D

Shivani Srivastava

Sheila Wang

snpro

Ran Liu

Sara Ahmed

Standard